Hydroxychloroquine as an Adjunct Therapy for Diabetes in Pregnancy

Int J Mol Sci. 2024 Sep 6;25(17):9681. doi: 10.3390/ijms25179681.

Abstract

This review discusses the pathophysiology of diabetes in pregnancy in relation to the placental function. We review the potential use of hydroxychloroquine in improving pregnancy outcomes affected by diabetes. The review focuses on the mechanism of action of hydroxychloroquine and its potential effects on diabetes. There are several pathways in which hydroxychloroquine mediates its effects: through the inflammasome complex, inflammatory cytokines, oxidative stress, modulatory effects, and antihyperglycemic effects. As a safe drug to be used in pregnancy, it is worth exploring the possible use hydroxychloroquine as an adjunct treatment to the current therapy of diabetes in pregnancy.

Keywords: diabetes; hydroxychloroquine; inflammation; placenta; pregnancy.

Publication types

  • Review

MeSH terms

  • Diabetes, Gestational* / drug therapy
  • Female
  • Humans
  • Hydroxychloroquine* / therapeutic use
  • Hypoglycemic Agents / therapeutic use
  • Oxidative Stress / drug effects
  • Placenta / drug effects
  • Placenta / metabolism
  • Pregnancy
  • Pregnancy Outcome

Substances

  • Hydroxychloroquine
  • Hypoglycemic Agents

Grants and funding

This research is supported by the Faculty of Medicine Fundamental Grant (GFFP) of the National University of Malaysia.